Synchrony Medical is a respiratory care technology company focused on improving airway clearance therapy for people with chronic lung conditions. Its flagship product, the FDA-cleared LibAirty™ Airway Clearance System, allows patients to perform daily home treatments that have demonstrated the ability to clear twice as much sputum as conventional therapies while increasing comfort and satisfaction. Commercially launched in late 2025, the device has received strong early adoption from both patients and clinicians. The company plans to use new capital to scale U.S. commercial operations, expand its clinical evidence base, and advance product development. Headquartered in Jersey City, New Jersey, with additional operations in Or Yehuda, Israel, Synchrony collaborates with leading pulmonologists from Sheba Medical Center and has been supported by Edge Medical Ventures’ EdgeLabs and the Israel Innovation Authority. Although revenue and user figures were not disclosed, the oversubscribed nature of the recent round underscores market demand and investor confidence in the company’s growth trajectory.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2026